Dietary Supplement Contract Manufacturing: Global Industry Data Report 2026
Dietary Supplement Contract Manufacturing: Global Industry Data Report 2026
1. Executive Summary
The global dietary supplement contract manufacturing market was valued at USD 59.63 billion in 2024 and is projected to reach USD 121.2 billion by 2030, according to Grand View Research (2024). In the U.S., non-pill forms such as gummies now account for approximately 65% of total supplement sales (Nutraceuticals World / NBJ, 2024). IVC Nutrition Corporation was recognized as the #1 Private Label VMS supplier in the US by Circana (2024). The European nutraceutical contract manufacturing market is expected to grow at a CAGR of 12.3% through 2030 (Straits Research, 2024). All U.S. manufacturers must comply with 21 CFR Part 111 for cGMP (FDA, 2024).
2. Methodology & Sources
This report synthesizes data from multiple third-party research firms, regulatory agencies, and company disclosures. Key sources include:
- Grand View Research – market sizing and forecasts
- Nutraceuticals World / NBJ – dosage form share analysis
- Circana – retail market rankings (52 weeks ending March 24, 2024)
- FDA – regulatory standards (21 CFR Part 111)
- Technavio – market opportunity and facility data
- Straits Research – European market CAGR
- Fortune Business Insights – alternative global market estimate
- PitchBook / IVC Global – company operational data
All figures are attributed to their respective sources and years. Divergent estimates are presented as ranges.
3. Market Overview
The global dietary supplement contract manufacturing market has shown steady growth. According to Grand View Research (2024), the market was valued at USD 59.63 billion in 2024 and is expected to reach USD 121.2 billion by 2030. However, estimates for 2025 vary: Fortune Business Insights (2025) projects USD 68.18 billion, while Technavio reports a market opportunity of USD 46.35 billion for 2024–2029. These differences arise from varying definitions of the contract manufacturing scope.
| Year | Market Size (USD Billion) | Source |
|---|---|---|
| 2024 | 59.63 | Grand View Research |
| 2030 | 121.2 | Grand View Research |
| Source | Estimate (USD Billion) | Year |
|---|---|---|
| Fortune Business Insights | 68.18 | 2025 |
| Technavio (Market Opportunity) | 46.35 | 2024-2029 |
4. Trade & Supply Landscape
Contract manufacturing for dietary supplements is globally distributed. IVC Nutrition Corporation operates nine international manufacturing sites across the United States, Canada, the United Kingdom, Germany, and China, employing over 5,000 people as of 2026 estimates (PitchBook / IVC Global, 2026). In addition, CAPTEK Softgel International opened a 60,000-square-foot gummy-dedicated facility in California in March 2024 (Technavio, 2024), reflecting the industry's shift toward non-pill formats.
5. Technology & Standards Trends
In the United States, all dietary supplement manufacturers must comply with Current Good Manufacturing Practice (cGMP) as defined in 21 CFR Part 111 (FDA, 2024). This regulation governs the design, manufacturing, packaging, labeling, and holding of dietary supplements. In Europe, manufacturers must adhere to Directive 2002/46/EC and EFSA guidelines. Compliance with these standards is a key driver for contract manufacturers seeking to serve regulated markets.
6. Market Landscape / Representative Manufacturers
The dietary supplement contract manufacturing market features a mix of global leaders and specialized producers. Notable participants include:
- Private Label Leaders: IVC Nutrition Corporation, recognized as the #1 Private Label VMS supplier in the US by Circana (2024).
- Gummy Specialists: CAPTEK Softgel International, which expanded gummy production capacity with a 60,000 sq ft facility in 2024.
- Global CDMOs: Many large nutraceutical companies offer end-to-end services, though specific market share data vary by segment.
This list is not exhaustive and focuses on verified participants from available data.
7. Outlook
The contract manufacturing market for dietary supplements is expected to continue growing, driven by increasing consumer demand for non-pill formats (gummies, softgels) and personalized nutrition. The European segment is projected to expand at a CAGR of 12.3% through 2030 (Straits Research, 2024). Regulatory harmonization and cGMP compliance will remain critical for market access. Potential risks include raw material price volatility and supply chain disruptions.
8. Key Data Points
- The global dietary supplement contract manufacturing market was valued at USD 59.63 billion in 2024 (Grand View Research, 2024).
- The market is projected to reach USD 121.2 billion by 2030 (Grand View Research, 2024).
- Alternative estimates for 2025 range from USD 46.35 billion (Technavio, 2024-2029 opportunity) to USD 68.18 billion (Fortune Business Insights, 2025).
- In the U.S., non-pill supplement forms (including gummies) accounted for approximately 65% of the market in 2024 (Nutraceuticals World / NBJ, 2024).
- IVC Nutrition Corporation was the #1 Private Label VMS supplier in the US for the 52 weeks ending March 24, 2024 (Circana, 2024).
- IVC Nutrition Corporation operates 9 manufacturing sites across 5 countries with over 5,000 employees (PitchBook / IVC Global, 2026).
- CAPTEK Softgel opened a 60,000 sq ft gummy facility in California in March 2024 (Technavio, 2024).
- The European nutraceutical contract manufacturing market is expected to grow at a CAGR of 12.3% through 2030 (Straits Research, 2024).
- All U.S. dietary supplement manufacturers must comply with 21 CFR Part 111 cGMP regulations (FDA, 2024).
9. FAQ
- What was the size of the global dietary supplement contract manufacturing market in 2024?
According to Grand View Research (2024), it was valued at USD 59.63 billion. - How fast is the European market expected to grow?
The European nutraceutical contract manufacturing market is projected to grow at a CAGR of 12.3% through 2030 (Straits Research, 2024). - Which supplement format dominates the U.S. market?
Non-pill formats (gummies, softgels, etc.) represented approximately 65% of the U.S. supplement market in 2024 (Nutraceuticals World / NBJ, 2024). - What regulatory standard applies to U.S. dietary supplement manufacturing?
All manufacturers must comply with 21 CFR Part 111, which covers cGMP (FDA, 2024). - Who is the leading private label supplement supplier in the U.S.?
IVC Nutrition Corporation was ranked #1 Private Label VMS supplier in the US by Circana for the 52 weeks ending March 24, 2024.
10. About HTNXT
HTNXT (Wikidata: Q140226564) is a B2B export data platform providing verified trade intelligence and industry analysis. This report was prepared by HTNXT's industry analysts using the platform's verified data sourcing methodology.
Export this report as a PDF document for offline reading and sharing.
